R&D News | pharmaphorum

News

University of Southampton scientist Prof Ali Tavassoli, who is Curve's chief scientific officer

UK biotech Curve swings £40.5m in Pfizer-backed round

Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug scree

News

Novo Nordisk joins molecular glue club with Neomorph deal

Big pharma’s interest in using protein degradation as a therapeutic strategy shows no sign of abating, as Novo Nordisk signs a wide-ranging deal with US biotech Neomorph t

News

Boehringer’s survodutide shows monster MASH potential

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the res

News

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea.

News

Sanofi trumpets win for oral BTK drug in chronic hives

Sanofi has not had the success it was hoping for with its oral BTK inhibitors, acquired as part of its $3.7 billion buyout of Principia Biopharma, but can now point to a w

News

Aptar buys digital health partner Healint

More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well

UK biotech Curve swings £40.5m in Pfizer-backed round

Novo Nordisk joins molecular glue club with Neomorph deal

Boehringer’s survodutide shows monster MASH potential

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

Sanofi trumpets win for oral BTK drug in chronic hives

Aptar buys digital health partner Healint

Compass points to strong psilocybin data in depression

How to meet your physicians where they are online

News

Editor's Picks